arrow
I

Ilaria Zampiva

Veneto Institute of Oncology IOV-IRCCS
H指数:10
被引数:411

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Outcomes of DNA Damage Repair Altered Metastatic Castration-Resistant Prostate Cancer: Insights from FFPE-Based Genomic Profiling

真实世界DNA损伤修复改变转移性去势抵抗性前列腺癌的结局:基于FFPE的基因组分析启示

Cancers
IF4.4
2026-07-260
OA
Interleukin-8 as a potential prognostic biomarker in renal cell carcinoma: a systematic review and meta-analysis

白细胞介素-8作为肾细胞癌潜在预后生物标志物:一项系统评价和荟萃分析

2025-09-010
OAAI
Clinical features and response to immune combinations in patients with renal cell carcinoma and sarcomatoid de-differentiation (ARON-1 study)
2024-09-070
OA
Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study

mRCC骨转移患者的钠水平和免疫治疗功效: Meet-Uro 15研究的子分析

2024-07-055
OAAI
Interleukin-8 in Colorectal Cancer: A Systematic Review and Meta-Analysis of Its Potential Role as a Prognostic Biomarker

结直肠癌的Interleukin-8: 其作为预后生物标志物的潜在作用的系统评价和荟萃分析

2022-10-1921
OAAI
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study
2022-03-0165
PRE
Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study
2021-04-0114
OAAI
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists
2020-10-1512
OAAI
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic
2020-08-0119
OAAI
Prognostic impact of proliferation for resected early stage 'pure' invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation

增殖对切除的早期 “纯” 浸润性小叶乳腺癌的预后影响: 根据组织学和临床验证对Ki67的截断分析

BREAST
IF7.9
2017-10-0119
PREAI
Prognostic model for advanced breast carcinoma with luminal subtype and impact of hormonal maintenance: Implications for post-progression and conditional survival
BREAST
IF7.9
2016-10-0110
PREAI